---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-006269"
form_type: "8-K/A"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:40:06.855524+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences CCO Kevin P. Danahy resigns effective immediately

## Summary
- Kevin P. Danahy, Chief Commercial Officer, resigned effective February 27, 2026.
- No reason for the resignation was disclosed in the filing.
- No replacement has been named at this time.

## SEC filing metadata
- accession: 0001437749-26-006269
- form_type: 8-K/A
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/0001437749-26-006269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/plse20260228d_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-006269
- JSON: https://secwatch.observer/filing/0001437749-26-006269.json
- Plain text: https://secwatch.observer/filing/0001437749-26-006269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.